ArticleHuman vaccines & immunotherapeutics2026
Cost-effectiveness analysis of finotonlimab in the treatment of advanced recurrent metastatic head and neck squamous cell carcinoma in China.
Yuan Gao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.